UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 306

Sortiert nach

Defining and Characterizing the Progression of Type 2 Diabetes

Diabetes care, 2009-11, Vol.32 (suppl 2), p.S151-S156

Fonseca, Vivian A

2009

Volltextzugriff (PDF)

Determinants of adherence to diabetes medications: findings from a large pharmacy claims database

Diabetes care, 2015-04, Vol.38 (4), p.604-609

2015

Volltextzugriff (PDF)

Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus

American journal of nephrology, 2019-01, Vol.49 (4), p.331-342

2019

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Endocrine practice, 2017-04, Vol.23 (Suppl 2), p.1-87

2017

Volltextzugriff (PDF)

Pax4 in Health and Diabetes

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8283

2023

Volltextzugriff (PDF)

The Human Side of Diabetes Care

Diabetes care, 2009-01, Vol.32 (1), p.1-2

Fonseca, Vivian A

2009

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

Endocrine practice, 2016-06, Vol.22 (6), p.753-762

2016

Volltextzugriff (PDF)

Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults

Diabetes care, 2010-01, Vol.33 (1), p.95-97

2010

Volltextzugriff (PDF)

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?

Diabetes care, 2008-08, Vol.31 (8), p.1672-1678

2008

Volltextzugriff (PDF)

Role of Iron in Diabetes and Its Complications

Diabetes care, 2007-07, Vol.30 (7), p.1926-1933

2007

Volltextzugriff (PDF)

Uric acid and diabetes: Is there a link?

Current pharmaceutical design, 2013, Vol.19 (27), p.4930

2013

Volltextzugriff (PDF)

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Diabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.384-392

2010

Volltextzugriff (PDF)

Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells

American journal of physiology. Renal physiology, 2020-01, Vol.318 (1), p.F67-F75

2020

Volltextzugriff (PDF)

New Developments in Diabetes Management: Medications of the 21st Century

Clinical therapeutics, 2014-04, Vol.36 (4), p.477-484

Fonseca, Vivian A., MD

2014

Volltextzugriff (PDF)

Ongoing Clinical Trials Evaluating the Cardiovascular Safety and Efficacy of Therapeutic Approaches to Diabetes Mellitus

The American journal of cardiology, 2011-08, Vol.108 (3), p.52B-58B

Fonseca, Vivian A., MD

2011

Volltextzugriff (PDF)

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

Diabetes care, 2008-08, Vol.31 (8), p.1479-1484

2008

Volltextzugriff (PDF)

Type 2 Diabetes and Hypertension: A Study on Bidirectional Causality

Circulation research, 2019-03, Vol.124 (6), p.930-937

2019

Volltextzugriff (PDF)

Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease

Journal of diabetes, 2023-02, Vol.15 (2), p.185-189

2023

Volltextzugriff (PDF)

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

Diabetes care, 2009-11, Vol.32 (11), p.S237-S245

2009

Volltextzugriff (PDF)

Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study

Diabetes care, 2020-11, Vol.43 (11), p.2776-2784

2020

Volltextzugriff (PDF)

Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors

Diabetes care, 2020-07, Vol.43 (7), p.1530-1536

2020

Volltextzugriff (PDF)

Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Randomized Trial

The American journal of medicine, 2013-02, Vol.126 (2), p.141-149

2013

Volltextzugriff (PDF)

Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications

Endocrine reviews, 2017-06, Vol.38 (3), p.173-188

2017

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(293)
Mit Volltextzugriff
(267)

Publikationsform

Sprache

Englisch
(306)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

Science & Technology
(202)
Life Sciences & Biomedicine
(200)
Humans
(180)
Endocrinology & Metabolism
(108)
Diabetes
(102)
Female
(92)
Male
(84)
Biological And Medical Sciences
(71)
Medical Sciences
(70)
Diabetes Mellitus, Type 2 - Drug Therapy
(67)
Middle Aged
(65)
Adult
(54)
Risk Factors
(54)
Hypoglycemic Agents - Therapeutic Use
(47)
Aged
(44)
Endocrinopathies
(43)
Diabetes. Impaired Glucose Tolerance
(41)
Endocrine Pancreas. Apud Cells
(41)
General & Internal Medicine
(39)
Diabetes Mellitus
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Defining and Characterizing the Progression of Type 2 Diabetes

Determinants of adherence to diabetes medications: findings from a large pharmacy claims database

Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE

Pax4 in Health and Diabetes

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2019 EXECUTIVE SUMMARY

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY

The Human Side of Diabetes Care

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS

Comparison of A1C and Fasting Glucose Criteria to Diagnose Diabetes Among U.S. Adults

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?

Role of Iron in Diabetes and Its Complications

Uric acid and diabetes: Is there a link?

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Blockade of sodium-glucose cotransporter 2 suppresses high glucose-induced angiotensinogen augmentation in renal proximal tubular cells

New Developments in Diabetes Management: Medications of the 21st Century

Ongoing Clinical Trials Evaluating the Cardiovascular Safety and Efficacy of Therapeutic Approaches to Diabetes Mellitus

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy

Type 2 Diabetes and Hypertension: A Study on Bidirectional Causality

Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestration

Baseline Vitamin D Status, Sleep Patterns, and the Risk of Incident Type 2 Diabetes in Data From the UK Biobank Study

Using the BRAVO Risk Engine to Predict Cardiovascular Outcomes in Clinical Trials With Sodium-Glucose Transporter 2 Inhibitors

Metanx in Type 2 Diabetes with Peripheral Neuropathy: A Randomized Trial

Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications

Suchergebnisse filtern